Home | All results_reference

[RDF data]
Results Reference #1143

Resource URI: http://static.linkedct.org/resource/results_reference/1143
linkedct:citation Matulonis U, Berlin S, Krasner C, et al.: Phase II study of cediranib (RECENTIN™, AZD2171) in recurrent epithelial ovarian cancer. [Abstract] American Association for Cancer Research: Molecular Targets and Cancer Therapeutics, October 22-26, 2007, San Francisco, CA A-B263, 2007.
rdfs:label Results Reference #1143
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00275028>
linkedct:results_reference_id 1143 (xsd:int)
rdf:type linkedct:results_reference